Europäische Union - Deutsch - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirale mittel zur systemischen anwendung - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Europäische Union - Deutsch - EMA (European Medicines Agency)

nova laboratories ireland limited - azathioprine - transplantatabstoßung - immunsuppressiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Europäische Union - Deutsch - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karzinom, nicht kleinzellige lunge - antineoplastische mittel - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

day zero ehf. - pirfenidon -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

day zero ehf. - pirfenidon -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

day zero ehf. - pirfenidon -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

day zero ehf. - pirfenidon -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

actavis group ptc ehf. - pirfenidon -

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

actavis group ptc ehf. - pirfenidon -

Europäische Union - Deutsch - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopathische lungenfibrose - immunsuppressiva - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).